Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx

Table 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx

Background<p>Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with poor prognosis. Efferocytosis, an essential process for clearing apoptotic cells, is involved in shaping immunosuppressive microenvironment, facilitating tumor immune evasion. This study aims to evaluate the...

Cur síos iomlán

Sábháilte in:

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Xiangjun Wang (2522917) (author)
Rannpháirtithe:	Wei Wang (17594) (author), Chuanxin Yang (18266948) (author), Puxiongzhi Wang (3877201) (author), Yangming Liu (12254459) (author), Liqin Yu (1461880) (author), Sijie Zhang (7429373) (author), Xiaoyu Yan (500545) (author), Jian Wang (5901) (author)
Foilsithe / Cruthaithe:	2025
Ábhair:	Genetic Immunology pancreatic ductal adenocarcinoma efferocytosis prognostic signature immunosuppressive microenvironment P2RY6 MRS-2578
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Table 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Table 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.docx
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 9_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 8_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 6_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 7_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 4_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 5_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 3_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 1_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Image 2_Efferocytosis-associated genes serve as prognostic biomarkers for pancreatic ductal adenocarcinoma and identify P2RY6 as a therapeutic target.tif
de réir: Xiangjun Wang (2522917)
Foilsithe / Cruthaithe: (2025)

Supplementary Data 1 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
de réir: Gregory L. Beatty (15087193)
Foilsithe / Cruthaithe: (2025)

Supplementary Data 2 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
de réir: Gregory L. Beatty (15087193)
Foilsithe / Cruthaithe: (2025)

Table 1_Cerebrospinal fluid proteomic profiling reveals potential biomarkers and altered pathways in myotonic dystrophy type 1.docx
de réir: Marwa Zafarullah (12527002)
Foilsithe / Cruthaithe: (2025)

Table 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.docx
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Table 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Table 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.xlsx
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 9_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 10_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 11_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 7_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 8_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 5_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 6_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 3_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 4_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 1_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Image 2_Succinylation heterogeneity in lung adenocarcinoma: from prognostic model to KLK6-driven tumor microenvironment remodeling.tif
de réir: Jichang Liu (1263291)
Foilsithe / Cruthaithe: (2025)

Data Sheet 3_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.pdf
de réir: Ping Liao (5424887)
Foilsithe / Cruthaithe: (2025)

Data Sheet 1_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.docx
de réir: Ping Liao (5424887)
Foilsithe / Cruthaithe: (2025)

Data Sheet 2_A novel TNFR2 agonist peptide for the expansion of CD4+Foxp3+ regulatory T cells.xls
de réir: Ping Liao (5424887)
Foilsithe / Cruthaithe: (2025)

Table 1_Machine learning-based differentiation of lung squamous cell carcinoma and adenocarcinoma using clinical-semantic and radiomic features.docx
de réir: Yanju Li (9697993)
Foilsithe / Cruthaithe: (2025)

Table 2_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
de réir: Rui Wang (52434)
Foilsithe / Cruthaithe: (2025)

Table 3_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.docx
de réir: Rui Wang (52434)
Foilsithe / Cruthaithe: (2025)

Table 1_Multi−cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma.xlsx
de réir: Rui Wang (52434)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S1 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
de réir: Erika Y. Faraoni (14844897)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S3 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
de réir: Erika Y. Faraoni (14844897)
Foilsithe / Cruthaithe: (2025)

Supplementary Table S4 from CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Cancer
de réir: Erika Y. Faraoni (14844897)
Foilsithe / Cruthaithe: (2025)

الإثبات بالتوقيع الرقمي في العقود الذكيّة باستخدام تقنية البلوك تشين بين الفقه الإسلامي وقانون المعاملات الإلكترونيّة الأردني وقانون البينات
de réir: Daoud, Hayel Abdel Hafeez Yousef
Foilsithe / Cruthaithe: (2025)

Data Sheet 3_Integrated liquid biopsy model for predicting metastasis and guiding PD-1 therapy in esophageal squamous cell carcinoma.pdf
de réir: Hailong Pang (12841991)
Foilsithe / Cruthaithe: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3fh43i7ikad2gltj051f986aqp